About this episode
Host Craig Beavers spoke with Arthur Allen, PharmD, for the latest updates from the RIVAWAR trial of rivaroxaban and a discussion of the newest Acute Coronary Syndrome Guidelines for left ventricular thrombus.
For more information:
Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association
Anticoagulation Forum Rapid Resources LV Thrombus
2025 ACC/AHA Guidelines
ACC 2025: Rivaroxaban Comparable to Warfarin in Left Ventricular Blood Clots
